Epidemiology of Endometrial Cancer in North of Iran
Abstract
Background: Endometrial cancer is the most common type of malignancy in female reproductive system and is the fourth common cancer after breast, lungs and colorectal cancers. Our aim is to report epidemiology and frequency types of endometrial cancer and clinical staging and grading of this disease.Methods: In this description and Cross-Sectional study, 75 patients with diagnosed endometrial cancer, being admitted to surgical ward of Rouhani Hospital or Shahid rajaii Hospital in Iran were enrolled to study. Demographic specification of patient, staging and grading and other variables related with endometrial cancer were collected and data was processed by SPSS version 18 software.Results: Disease of diabetes, hypertension and obesity had a frequency of 36%, 26.7% and 85.3% in orderly. The mean of abortion was 0.47, mean of delivery was 3.71, mean age of menarche was 13.73 and most frequent age of first delivery belonged to the range of 19-24 year old (47ones, 62.7%). A high percentage of patients had been menopause under 39 years of age (25 ones, 33.3%). 3 patients (4%) had a history of breast cancer and usage of Tamoxifen. Only 6 cases (8%) had a history of irregularities menstruation. 58 of patients were in stage1 and 17 were other stages. 77.2% of patients have endometrioid and 13 patients were suffered by sarcoma.Conclusion: Most patients with endometrial cancer had endometrioid. Times of delivery and abortion, lower age of menarche and age of menopause and at the first delivery have been appeared to be associated with endometrial cancer.Case AS, Rocconi RP, Straughn JM Jr, Conner M, Novak L, Wang W, et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer.Obstet Gynecol2006
;108(6):1375-9.
Arab M, Noghabaei G. Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries. Iran J Public Health. 2014; 43(10): 1372–1379.
Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstetrics and Gynecology. 1984; 64(3): 417-420.
Sherman ME. Devesa SS. Analysis of racial differences in incidence,survival,and mortality for malignant tumors of the uterine corpus .Cancer. 2003 ;98(1): 176 86.
Madison T, Schottenfeld D, James SA, Schwartz AC, et al. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment and survival. Am J Public Health. 2004; 94: 2104-2111.
Wright JD, Fiorelli J, Schiff PB, et al. Racial disparities for uterine corpus tumors.Changes in clinical characteristics and treatment over time. Cancer. 2009; 115: 1276-1285.
Setiawan VW, Pike MC, Kolonel LN. Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol. 2007; 165: 262-270.
Voskuil DW, Monninkhof EM, Elias SG. Task force physical activity and cancer. Physical activity and endometrial cancer risk, a systematic review of current evidence. Cancer Epidemiol Biomarkers Prev. 2007; 16(4): 639-648.
Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am. 2012; 26(1): 1-12.
Mehasseb MK, Latimer JA. Controversies in the Management of Endometrial Carcinoma: an update. Obstet Gynecol Int. 2012; 2012: 676032.
David M. Purdie, Adèle C. Green. Epidemiology of endometrial cancer. Best Practice & Research Clinical Obstetrics & Gynaecology. 2001; 15(3): 341–354.
Momtahen S, Kadivar M, Kazzazi AS, Gholipour F. Assessment of gynecologic malignancies: A multi-center study in Tehran (1995-2005). Indian Journal of Cancer July-September, 2009; 46 (3): 226-230.
Łapińska-Szumczyk S, Emerich J. Obesity, hypertension and diabetes mellitus in patients with endometrial cancer.Ginekol Pol. 2003; 74(4): 274-81.
Bratos K, Roszak A, Cikowska-Woźniak E, Niecewicz P. Analysis of epidemiologic risk factors for endometrial cancer. Ginekol Pol. 2002; 73(11): 945-50.
Parslov M, Lidegaard J, Sci D. Risk factors among young women with endometrial cancer: A Danish case-control study. American Journal of Obstetrics and Gynecology January. 2000; 182 (1): 23-29.
Reis N, Kizilkaya Beji N. Risk factors for endometrial cancer in Turkish women: Results from a hospital-based case–control study.European Journal of Oncology Nursing April. 2009; 13 (2): 122–127.
Dalbert DB, Rodríguez de la Peña MM, Figueredo A, Mural J, Bartt O, Subiela R, Rossi C, Bazán G. Tamoxifen and endometrial disease in patients with breast cancer. Medicina (B Aires). 2013; 73(2): 97-103.
Salmi T, et al. Endometrial carcinoma risk factors, with special reference to the use of oestrogens. Acta Endocrinol Suppl (Copenh). 1980; 233: 37-43.
McDonald TW, Annegers JF, et al. Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol. 1977; 15; 127(6): 572-80.
Gerber J, Sozański L, Suchocki S. The risk factors of endometrial cancer. Ginekol Pol. 2001; 72(12A): 1418-22.
Files | ||
Issue | Vol 8 No 4 (2016) | |
Section | Brief Communications | |
Keywords | ||
Endometrial cancer Delivery malignancy |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |